The Min mouse: A genetic model for intestinal carcinogenesis

Toxicologic Pathology

Volumn 25, Issue 3, 1997, Pages 329-332

  Thompson, M B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DNA; ETHYLNITROSOUREA; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENESIS; FEMALE; GENETIC MODEL; GENETIC PREDISPOSITION; HISTOPATHOLOGY; INTESTINE CANCER; MALE; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0030913779     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339702500312     Document Type: Review

References (31)

1. Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B, and Kinzler K (1996). Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 17: 1756-1760.
2. Campbell WJ, Spence RAJ, and Parks TG (1994). Familial adenomatous polyposis. Br. J. Surg. 81: 1722-1733.
3. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, and Dove W (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639.
4. Dove WF, Gould KA, Luongo C, Moser AR, and Shoemaker AR (1995). Emergent issues in the genetics of intestinal neoplasia. Cancer Surv. 25: 335-355.
5. Dunlop MG (1992). Colorectal cancer genetics. Sem. Cancer Biol. 3: 131-140.
6. Fearon ER and Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
7. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan M, and Kucherlapati R (1994). A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA 91: 8969-8973.
8. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, and Offerhaus GJA (1993). Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328: 1313-1316.
9. Giardiello FM, Krush AJ, Petersen GM, Booker SV, Kerr M, Tong LL, and Hamilton SR (1994). Phenotypic variability of familial adenomatous polyposis in 11 unrelated familities with identical APC gene mutations. Gastroenterology 106: 1542-1547.
10. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56: 710-714.
11. Kennedy AR, Beazer-Barclay Y, Kinzler K, and Newberne PM (1996). Suppression of carcinogenesis in the intestines of Min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res. 56: 679-682.
12. Kinzler KW and Vogelstein B (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
13. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, and Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205.
14. Leppert M, Burt R, Hughes JP, Samowitz W, Nakamura Y, Woodward S, Gardner E, Lalouel JM, and White R (1990). Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N. Engl. J. Med. 322: 904-908.
15. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, and Kinzler K (1994). Inactivation of both APC alleles in human and mouse tumors. Cancer Res. 54: 5953-5958.
16. Luongo C, Gould KA, Su L-K, Kinzler KW, Vogelstein B, Dietrich W, Lander ES, and Moser AR (1993). Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse. Genomics 15: 3-8.
17. + in intestinal adenomas from Min mice. Cancer Res. 54: 5947-5952.
18. Min-induced intestinal neoplasia. Cell 81: 957-966.
19. Moser AR, Dove WF, Roth KA, and Gordon JI (1992). The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 116: 1517-1526.
20. Moser AR, Pilot HC, and Dove WF (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
21. Moser AR, Shoemaker AR, Connelly CS, Clipson L, Gould KA, Luongo C, Dove WF, Siggers PH, and Gardner RL (1995). Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dyn. 203: 422-433.
22. Nagase H and Nakamura Y (1993). Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat. 2: 425-434.
23. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809.
24. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, and Taketo M (1995). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92: 4482-4486.
25. Oshima M, Oshima H, Kobayashi M, Tsutsumi M, and Taketo MM (1995). Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res. 55: 2719-2722.
26. Paul P, Letteboer T, Gelbert L, Groden J, White R, and Coppes MJ (1993). Identical exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum. Mol. Genet. 2: 925-931.
27. 2 (PLA2S-II), maps to 1p35-36.1/D1S199. Cancer Res. 55: 5504-5506.
28. 2 gene alterations in human colorectal cancer. Cancer Res. 55: 5184-5186.
29. 2 genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res. 56: 955-958.
30. Su L-K, Johnson KA, Smith KJ, Hill DE, Vogelstein B, and Kinzler KW (1993). Association between wild type and mutant APC gene products. Cancer Res. 53: 2728-2731.
31. Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, and Dove WF (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.